Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity-Reference-Cited by-同舟云学术

Correlation of plasma anti-tuberculosis drug levels with subsequent development of hepatotoxicity

Published:2014-02-01 Issue:2 Volume:18 Page:188-195
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Satyaraddi A.¹,Velpandian T.²,Sharma S. K.¹,Vishnubhatla S.³,Sharma A.⁴,Sirohiwal A.⁵,Makharia G. K.⁶,Sinha S.¹,Biswas A.¹,Singh S.⁷

Affiliation:

1. Department of Medicine, All India Institute of Medical Sciences, New Delhi, India

2. Department of Ocular Pharmacology and Pharmacy, Dr Rajender Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

3. Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India

4. Medical University, Pleven, Bulgaria

5. Department of Ophthalmology, Dr Rajender Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India

6. Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India

7. Department of Laboratory Medicine, All India Institute of Medical Sciences, New Delhi, India

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic drug monitoring in tuberculosis;European Journal of Clinical Pharmacology;2024-09-06

2. Incidence and risk factors of antituberculosis drug-induced liver injury in India: A systematic review and meta-analysis;Indian Journal of Gastroenterology;2024-09-03

3. Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness;2024-08-31

4. Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective;Pharmaceutics;2024-03-12

5. Association of Cytochrome P450 2E1 and N- Acetyltransferase 2 Genotypes with Serum Isoniazid Level and Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Cross-Sectional Study;IRAN J MED SCI;2023